Department of Orthopedic Surgery, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.
Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.
Int J Mol Sci. 2022 Aug 4;23(15):8674. doi: 10.3390/ijms23158674.
Ubiquitin-specific protease 7 (USP7) is highly expressed in a variety of malignant tumors. However, the role of USP7 in regulating self-renewal and differentiation of human bone marrow derived mesenchymal stromal cells (hBMSCs) remains unknown. Herein, we report that USP7 regulates self-renewal of hBMSCs and is required during the early stages of osteogenic, adipogenic, and chondrogenic differentiation of hBMSCs. USP7, a deubiquitinating enzyme (DUB), was found to be downregulated during hBMSC differentiation. Furthermore, USP7 is an upstream regulator of the self-renewal regulating proteins SOX2 and NANOG in hBMSCs. Moreover, we observed that SOX2 and NANOG are poly-ubiquitinated and their expression is downregulated in USP7-deficient hBMSCs. Overall, this study showed that USP7 is required for maintaining self-renewal and multipotency in cultured hBMSCs. Targeting USP7 might be a novel strategy to preserve the self-renewal capacity of hBMSCs intended for stem cell therapy.
泛素特异性蛋白酶 7(USP7)在多种恶性肿瘤中高度表达。然而,USP7 在调节人骨髓间充质基质细胞(hBMSCs)的自我更新和分化中的作用尚不清楚。在此,我们报道 USP7 调节 hBMSCs 的自我更新,并在 hBMSCs 的成骨、成脂和成软骨分化的早期阶段是必需的。去泛素化酶(DUB)USP7 在 hBMSC 分化过程中下调。此外,USP7 是 hBMSCs 中自我更新调节蛋白 SOX2 和 NANOG 的上游调节剂。此外,我们观察到 SOX2 和 NANOG 多聚泛素化,其在 USP7 缺陷型 hBMSCs 中的表达下调。总的来说,这项研究表明 USP7 对于维持培养的 hBMSCs 的自我更新和多能性是必需的。靶向 USP7 可能是一种保留用于干细胞治疗的 hBMSCs 自我更新能力的新策略。